SCHEMBL4049152

SCHEMBL4049152

CN1CC[C@H](c2c3n(c4ccc(OC5CCCC5)cc24)S(=O)(=O)c2ccccc2-3)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.41
PARP1 P09874 3/20 0.37
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.34
USP2 O75604 1/20 0.34
USP1 O94782 1/20 0.34
USP8 P40818 1/20 0.34
OTUB1 Q96FW1 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTT P42858 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
PRMT5 O14744 3/20 0.34
WDR77 Q9BQA1 3/20 0.34
MAOA P21397 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4058810 1.00 HTR6 (0.41) HTR6PARP1KDM4EATMUSP2
SCHEMBL14177903 1.00 HTR6 (0.41) HTR6PARP1KDM4EATMUSP2
SCHEMBL3324374 0.88 HTR6 (0.53) HTR6KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL4058308 0.88 HTR6 (0.53) HTR6KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL4049451 0.88 HTR6 (0.53) HTR6KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL4054154 0.86 HTR6 (0.44) HTR6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL14177900 0.86 HTR6 (0.44) HTR6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL4058499 0.86 HTR6 (0.42) HTR6KDM4EATMCYP1A2CYP2C9
SCHEMBL4048282 0.86 HTR6 (0.44) HTR6CYP1A2CYP2C9CYP2C19HTT
SCHEMBL14177905 0.86 HTR6 (0.42) HTR6KDM4EATMCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1704154-B1 NOVEL INDENO [2,1A]INDENES AND ISOINDOL [2,1-A]INDOLES SUVEN LIFE SCIENCES LTD (IN) 2009-05-06 EP claimed
US-7388024-B2 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles SUVEN LIFE SCIENCES LIMITED (IN) 2008-06-17 US claimed
US-20070054946-A1 Novel indeno[2,1A]indenes and isoindolo[2,1-A]indoles SUVEN LIFE SCIENCES LIMITED (IN) 2007-03-08 US claimed
EP-1704154-A1 NOVEL INDENO [2,1A]INDENES AND ISOINDOL [2,1-A]INDOLES Suven Life Sciences Limited (IN) 2006-09-27 EP claimed
WO-2005066184-A1 NOVEL INDENO[2,1A]INDENES AND ISOINDOL[2,1-A]INDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2005-07-21 WO claimed
EP-1704154-B1 NOVEL INDENO [2,1A]INDENES AND ISOINDOL [2,1-A]INDOLES SUVEN LIFE SCIENCES LTD (IN) 2009-05-06 EP disclosed
US-7388024-B2 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles SUVEN LIFE SCIENCES LIMITED (IN) 2008-06-17 US disclosed
US-20070054946-A1 Novel indeno[2,1A]indenes and isoindolo[2,1-A]indoles SUVEN LIFE SCIENCES LIMITED (IN) 2007-03-08 US disclosed
EP-1704154-A1 NOVEL INDENO [2,1A]INDENES AND ISOINDOL [2,1-A]INDOLES Suven Life Sciences Limited (IN) 2006-09-27 EP disclosed
WO-2005066184-A1 NOVEL INDENO[2,1A]INDENES AND ISOINDOL[2,1-A]INDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2005-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070054946-A1 Novel indeno[2,1A]indenes and isoindolo[2,1-A]indoles IDO1, IDO2, OPRD1 HTR6 166/4885PARP1 946/4885KDM4E 1535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.